Drug:
Reaction: GASTROINTESTINAL DISORDER
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940176 |
EU |
77 | 2 |
Hepatotoxicity, Gastrointestinal disorder, Disease progression, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 2 | 26940265 |
AU |
43 | 2 |
Gastrointestinal disorder, Hepatitis, |
||||
OLMESARTAN MEDOXOMIL, |
||||
| 3 | 26940321 |
US |
2 | |
Fatigue, Gastrointestinal disorder, |
||||
ABALOPARATIDE, |
||||
| 4 | 26940347 |
US |
1 | |
Stress, Diarrhoea, Gastrointestinal disorder, Flushing, |
||||
DIMETHYL FUMARATE, |
||||
| 5 | 26940400 |
US |
1 | |
Gastrointestinal disorder, Gastrointestinal disorder, Pain, Joint swelling, Off label use, |
||||
TOCILIZUMAB, ABATACEPT, |
||||
| 6 | 26940434 |
US |
2 | |
Gastrointestinal disorder, |
||||
ORFORGLIPRON, |
||||
| 7 | 26940544 |
US |
51 | |
Pyrexia, Gastrointestinal disorder, |
||||
NIVOLUMAB, |
||||
| 8 | 26940575 |
CA |
49 | 2 |
Angina pectoris, Abdominal discomfort, Asthenia, Cough, Decreased appetite, Dehydration, Dyspnoea exertional, Gastrointestinal disorder, General physical health deterioration, Inflammation, Influenza like illness, Presyncope, Productive cough, Abdominal pain, Abdominal pain upper, Constipation, Diarrhoea, Fatigue, Headache, Nasopharyngitis, Nausea, Oral fungal infection, Upper respiratory tract infection, Viral infection, Condition aggravated, Pain, Rhinorrhoea, Therapeutic product effect delayed, Therapeutic response shortened, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, |
||||
| 9 | 26940631 |
US |
2 | |
Dysarthria, Gastrointestinal disorder, Dyspnoea, |
||||
ABALOPARATIDE, |
||||
| 10 | 26940727 |
US |
2 | |
Brain fog, Medical procedure, Condition aggravated, Urticaria, Migraine, Gastrointestinal disorder, Drug ineffective, |
||||
AVAPRITINIB, |
||||
| 11 | 26940928 |
US |
2 | |
Gastrointestinal disorder, |
||||
ABALOPARATIDE, USTEKINUMAB, |
||||
| 12 | 26941032 |
US |
75 | 2 |
Alopecia, Gastrointestinal disorder, Gout, Blood thyroid stimulating hormone increased, Abdominal distension, Blood pressure increased, Bone pain, Pruritus, |
||||
ABALOPARATIDE, |
||||
| 13 | 26941220 |
US |
2 | |
Gastrointestinal disorder, |
||||
ZANUBRUTINIB, VENETOCLAX, |
||||
| 14 | 26941250 |
US |
||
Gastrointestinal disorder, |
||||
| 15 | 26941277 |
US |
2 | |
Intentional product misuse, Gastrointestinal disorder, Constipation, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 16 | 26941340 |
US |
||
Gastrointestinal disorder, Abdominal distension, Menstruation irregular, Product dose omission issue, |
||||
NORGESTIMATE AND ETHINYL ESTRADIOL, |
||||
| 17 | 26941354 |
US |
53 | 2 |
Colitis microscopic, Gastrointestinal disorder, Pain, Muscle spasms, Micturition urgency, Fatigue, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, |
||||
| 18 | 26941648 |
US |
2 | |
Gastrointestinal disorder, Head deformity, Bone disorder, Extramedullary haemopoiesis, Megakaryocytes increased, |
||||
ABALOPARATIDE, |
||||
| 19 | 26941931 |
CA |
40 | 2 |
Pneumonia, Migraine, Depression, Dyspepsia, Systemic lupus erythematosus, Hepatitis, Back injury, Blister, Vomiting, Peripheral venous disease, Hypertension, Malaise, Osteoarthritis, Joint swelling, Coeliac disease, Abdominal distension, Bursitis, Hypercholesterolaemia, Taste disorder, Hypersensitivity, Rheumatic fever, Arthropathy, Contusion, Fibromyalgia, Injury, Dry mouth, Rheumatoid arthritis, Gait inability, Infusion related reaction, Nail disorder, Arthralgia, Dyspnoea, Insomnia, Drug hypersensitivity, Synovitis, Gastrointestinal disorder, Stomatitis, Helicobacter infection, Neck pain, Psoriatic arthropathy, Hypoaesthesia, Sleep disorder, Injection site reaction, Irritable bowel syndrome, Onychomadesis, Duodenal ulcer perforation, Pericarditis, Nasopharyngitis, Hand deformity, Pemphigus, Alopecia, |
||||
ERENUMAB-AOOE, ETANERCEPT, ETANERCEPT, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, SECUKINUMAB, SECUKINUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, FOLIC ACID, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, MEPOLIZUMAB, TOFACITINIB, TOFACITINIB, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, |
||||
| 20 | 26942223 |
US |
45 | 1 |
Gastrointestinal disorder, Feeling abnormal, Nausea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, |
||||
| 21 | 26942275 |
AR |
80 | 2 |
Gastrointestinal disorder, Red blood cell count decreased, Hangnail, Pain in extremity, Abdominal discomfort, Feeding disorder, Oral discomfort, Aphonia, |
||||
PANITUMUMAB, SOTORASIB, SOTORASIB, |
||||
| 22 | 26942284 |
US |
75 | 2 |
Gastrointestinal disorder, Treatment delayed, Diarrhoea, Nausea, Pain, |
||||
OSIMERTINIB, |
||||
| 23 | 26942507 |
EU |
2 | |
Gastrointestinal disorder, |
||||
NINTEDANIB, |
||||
| 24 | 26942589 |
GB |
77 | 2 |
Gastrointestinal disorder, |
||||
ORAL SEMAGLUTIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, BISOPROLOL FUMARATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, FLUVASTATIN, RAMIPRIL, PERMETHRIN, PERMETHRIN CREAM 5% W/W, LANSOPRAZOLE, NEOMYCIN SULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, EMPAGLIFLOZIN, DAPAGLIFLOZIN, |
||||
| 25 | 26942631 |
US |
72 | 2 |
Gastrointestinal disorder, Product dose omission issue, |
||||
POMALIDOMIDE, ERGOCALCIFEROL, ESCITALOPRAM, FAMOTIDINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LEVOTHYROXINE SODIUM, |
||||
| 26 | 26942816 |
US |
2 | |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, |
||||
| 27 | 26942897 |
CN |
||
Decreased appetite, Gastrointestinal disorder, Myelosuppression, Hepatic function abnormal, Renal impairment, Proteinuria, |
||||
BEVACIZUMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), CISPLATIN, |
||||
| 28 | 26942978 |
US |
||
Gastrointestinal disorder, |
||||
ORAL SEMAGLUTIDE, |
||||
| 29 | 26943057 |
CA |
||
Drug ineffective, Pain in extremity, Wound, Injection site irritation, Injection site erythema, Urticaria, Blood immunoglobulin G increased, Injection site pruritus, Peripheral swelling, Gastrointestinal disorder, Impaired healing, Injection site pain, Blood immunoglobulin G decreased, Illness, Discomfort, Rash, Fear of injection, |
||||
PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, HUMAN IMMUNOGLOBULIN G, PRAZOSIN HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, MORPHINE SULFATE, MORPHINE SULFATE, PREGABALIN, DIMENHYDRINATE, SERTRALINE HYDROCHLORIDE, SUMATRIPTAN SUCCINATE, |
||||
| 30 | 26943112 |
CA |
44 | 2 |
Breast cancer stage III, Folliculitis, Sciatica, Hypoaesthesia, Memory impairment, Dyspepsia, Taste disorder, Crohn^s disease, Bone erosion, Gait inability, Gastrooesophageal reflux disease, Pneumonia, Decreased appetite, Insomnia, Disability, Confusional state, Grip strength decreased, Sleep disorder due to a general medical condition, Product use in unapproved indication, Blister, Adjustment disorder with depressed mood, Dislocation of vertebra, Hypercholesterolaemia, Lip dry, Blepharospasm, Systemic lupus erythematosus, Therapeutic product effect decreased, Anxiety, Delirium, Impaired healing, Infusion site reaction, Malaise, Bursitis, Facet joint syndrome, Lower respiratory tract infection, Dyspnoea, Drug intolerance, Prescribed overdose, Helicobacter infection, Dizziness, Sleep disorder, Rash, Glossodynia, C-reactive protein increased, Ulcer haemorrhage, Incorrect route of product administration, Therapeutic product effect incomplete, Maternal exposure during pregnancy, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Respiratory disorder, Psoriatic arthropathy, Urticaria, Depression, Contusion, Hepatic cirrhosis, Product quality issue, Hypersensitivity, Blood cholesterol increased, Drug hypersensitivity, Sinusitis, Exostosis, Discomfort, Deep vein thrombosis postoperative, Intentional product use issue, Condition aggravated, Diarrhoea, Hand deformity, Gait disturbance, Lower limb fracture, X-ray abnormal, Pericarditis, Stomatitis, Back injury, Duodenal ulcer perforation, Lupus-like syndrome, Ear pain, Ill-defined disorder, Alopecia, Fatigue, Synovitis, Type 2 diabetes mellitus, Prescribed underdose, Exposure during pregnancy, Rheumatoid factor positive, Product use issue, Epilepsy, Rheumatoid arthritis, Gastrointestinal disorder, Swollen joint count increased, Red blood cell sedimentation rate increased, Treatment failure, Irritable bowel syndrome, Contraindicated product administered, Swelling, Hypertension, Breast cancer stage II, Laryngitis, Drug ineffective, Pyrexia, Asthenia, Headache, Medication error, General physical health deterioration, Asthma, Therapy non-responder, Hepatic enzyme increased, Chest pain, Rheumatic fever, Drug tolerance, Fibromyalgia, Dry mouth, Peripheral swelling, Infusion related reaction, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, INFLIXIMAB, ABATACEPT, OXYCODONE, OXYCODONE, CELECOXIB, CELECOXIB, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, SECUKINUMAB, MEPOLIZUMAB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CELECOXIB, CELECOXIB, RAMIPRIL, RAMIPRIL, LAMOTRIGINE, LAMOTRIGINE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, PREDNISONE, |
||||
| 31 | 26943497 |
81 | 2 | |
Colitis, Gastrointestinal disorder, Lung disorder, Asthenia, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 32 | 26943608 |
52 | 2 | |
Gastrointestinal disorder, Pyrexia, Abdominal distension, Weight increased, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 33 | 26944015 |
GB |
1 | |
Pulmonary fibrosis, Gastrointestinal disorder, |
||||
NINTEDANIB, CANDESARTAN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, LANSOPRAZOLE, MORPHINE SULFATE, |
||||
| 34 | 26944034 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Epilepsy, Anxiety, Ankle fracture, Migraine, Hypertension, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Diarrhoea, Nausea, Vomiting, Blood alkaline phosphatase increased, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, Foot fracture, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Dizziness, White blood cell count decreased, Haematocrit decreased, Haemoglobin decreased, Depression, Skin discolouration, Malaise, Emotional distress, Headache, Abnormal behaviour, Ligament sprain, Myopia, Colitis, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Petit mal epilepsy, Choking, Asphyxia, Sarcoma, Metastases to lung, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Electric shock sensation, Full blood count decreased, Fat tissue increased, Fluid retention, Pain, Dry eye, Back pain, Fatigue, Dysgeusia, Abdominal discomfort, Diarrhoea, Headache, Depressed mood, Memory impairment, Weight decreased, Blood sodium increased, Aversion, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Gastrointestinal disorder, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Red cell distribution width increased, Elliptocytosis, Atrioventricular block first degree, Discomfort, Mean cell volume increased, Blood glucose increased, Rouleaux formation, Red blood cell sedimentation rate increased, Limb deformity, Oral herpes, Ill-defined disorder, Arthritis, Hypersensitivity, Pruritus, Pyrexia, Dry skin, Lymphocyte count decreased, Red blood cell count decreased, Decreased immune responsiveness, Thyroid mass, Visual impairment, Neoplasm, Gingival disorder, Pain in extremity, Vision blurred, Chills, Herpes virus infection, Agitation, Confusional state, Catheter site pain, Gastrooesophageal reflux disease, Oesophagitis, Stress, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Viral diarrhoea, Nasopharyngitis, Alopecia, Tension headache, |
||||
ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, CALCIUM, MORPHINE, |
||||
| 35 | 26944205 |
US |
48 | 2 |
Gastrointestinal disorder, Insomnia, Panic attack, Anxiety, Depersonalisation/derealisation disorder, |
||||
| 36 | 26944206 |
VN |
50 | 2 |
Bone pain, Dyspnoea, Metastases to liver, Gastrointestinal disorder, Gastritis, Enteritis, Pyrexia, Cough, |
||||
CERITINIB, CERITINIB, CERITINIB, ZOLEDRONIC ACID, |
||||
| 37 | 26944362 |
CA |
44 | 2 |
Liver injury, Folliculitis, Gait inability, Headache, Nasopharyngitis, Night sweats, Lower respiratory tract infection, Musculoskeletal pain, Lung disorder, Impaired healing, Hand deformity, Muscle injury, Intentional product use issue, Hypersensitivity, Drug hypersensitivity, Glossodynia, Hypoaesthesia, Fatigue, Helicobacter infection, Musculoskeletal stiffness, Muscle spasms, Injury, Lower limb fracture, Joint swelling, Facet joint syndrome, Gastrointestinal disorder, Fibromyalgia, Drug intolerance, Deep vein thrombosis postoperative, Decreased appetite, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, DICLOFENAC SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, |
||||
| 38 | 26944454 |
US |
13 | 1 |
Gastrointestinal disorder, Oral infection, Ingrowing nail, |
||||
| 39 | 26944909 |
US |
2 | |
Headache, Nausea, Gastrointestinal disorder, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 40 | 26944949 |
US |
2 | |
Hospitalisation, Shoulder operation, Adverse drug reaction, Gastrointestinal disorder, Nausea, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 41 | 26944957 |
US |
||
Gastrointestinal disorder, Abdominal distension, Abdominal pain upper, Diarrhoea, |
||||
PALTUSOTINE, PALTUSOTINE, CARVEDILOL, LISINOPRIL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PREGABALIN, CALCIUM, FERROUS SULFATE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LANSOPRAZOLE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, CANAGLIFLOZIN, INSULIN GLARGINE, INSULIN ASPART, TESTOSTERONE, ORAL SEMAGLUTIDE, ERGOCALCIFEROL, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, |
||||
| 42 | 26945229 |
US |
1 | |
Gastrointestinal disorder, Drug intolerance, |
||||
| 43 | 26945238 |
US |
2 | |
Gastrointestinal disorder, Weight decreased, |
||||
ABALOPARATIDE, |
||||
| 44 | 26945299 |
US |
||
Bone pain, Pruritus, Gastrointestinal disorder, Rash erythematous, Off label use, |
||||
AVAPRITINIB, |
||||
| 45 | 26945365 |
US |
||
Gastrointestinal disorder, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 46 | 26945411 |
US |
21 | 1 |
Blood calcium increased, Gastrointestinal disorder, Abdominal pain upper, Back pain, Product administered at inappropriate site, Product prescribing issue, |
||||
ABALOPARATIDE, TESTOSTERONE, TESTOSTERONE, |
||||
| 47 | 26945420 |
US |
38 | 1 |
Pain in extremity, Gastrointestinal inflammation, Incision site ulcer, Gastrointestinal disorder, Drug ineffective, Muscle disorder, Crohn^s disease, |
||||
UPADACITINIB, |
||||
| 48 | 26945443 |
US |
64 | 2 |
Gastrointestinal disorder, Headache, |
||||
ABALOPARATIDE, |
||||
| 49 | 26945885 |
US |
2 | |
Nausea, Dizziness, Fatigue, Headache, Gastrointestinal disorder, |
||||
ABALOPARATIDE, PHENTERMINE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, |
||||
| 50 | 26946176 |
US |
1 | |
Gastrointestinal disorder, Hypotension, |
||||
SPARSENTAN, |
||||
| 51 | 26946212 |
US |
2 | |
Gastrointestinal disorder, |
||||
ABALOPARATIDE, |
||||
| 52 | 26946242 |
US |
2 | |
Gastrointestinal disorder, Myalgia, Palpitations, Dizziness, Nausea, Injection site erythema, Arthralgia, |
||||
ABALOPARATIDE, |
||||
| 53 | 26946565 |
US |
1 | |
Gastrointestinal disorder, Nausea, |
||||
ABALOPARATIDE, |
||||
| 54 | 26946586 |
US |
2 | |
Dyspepsia, Gastrointestinal disorder, |
||||
ABALOPARATIDE, |
||||
| 55 | 26946787 |
US |
||
Gastrointestinal disorder, Inflammation, Off label use, |
||||
RUXOLITINIB, |
||||
| 56 | 26947274 |
US |
1 | |
Weight increased, Gastrointestinal disorder, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 57 | 26947309 |
US |
2 | |
Gastrointestinal disorder, Flatulence, Frequent bowel movements, Anal incontinence, Headache, Pain, Fatigue, Arthralgia, Pain in extremity, |
||||
ABALOPARATIDE, |
||||
| 58 | 26947315 |
US |
23 | 1 |
Gastrointestinal disorder, Condition aggravated, Abdominal pain, Product use issue, |
||||
ABALOPARATIDE, ADALIMUMAB-ADAZ, |
||||
| 59 | 26947349 |
CA |
43 | |
Confusional state, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Liver disorder, Lower limb fracture, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Pyrexia, Rash, Rheumatoid arthritis, Rheumatoid factor positive, Sciatica, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Nasopharyngitis, Sinusitis, Wound infection, Drug intolerance, Treatment failure, Contraindicated product administered, Off label use, Product use in unapproved indication, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM, CALCIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB-ADAZ, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RISEDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TOFACITINIB CITRATE, TOFACITINIB CITRATE, VITAMIN C, ERGOCALCIFEROL, ERGOCALCIFEROL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 60 | 26947415 |
US |
2 | |
Gastrointestinal disorder, Palpitations, |
||||
ABALOPARATIDE, |
||||
| 61 | 26947452 |
US |
2 | |
Head discomfort, Gastrointestinal disorder, Brain fog, Condition aggravated, Heart rate increased, Condition aggravated, Dyspnoea, Fatigue, Dizziness, Vertigo, |
||||
ABALOPARATIDE, |
||||
| 62 | 26947456 |
US |
65 | 2 |
Gastrointestinal disorder, Brain fog, Post-acute COVID-19 syndrome, Headache, Nausea, Dizziness, Palpitations, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 63 | 26947503 |
US |
2 | |
Vision blurred, Muscular weakness, Gastrointestinal disorder, Condition aggravated, Arthralgia, |
||||
ABALOPARATIDE, VEDOLIZUMAB, |
||||
| 64 | 26947580 |
US |
2 | |
Musculoskeletal stiffness, Joint stiffness, Gastrointestinal disorder, Nausea, Dizziness, Fatigue, |
||||
ABALOPARATIDE, |
||||
| 65 | 26947707 |
US |
2 | |
Abdominal rigidity, Gastrointestinal disorder, Abdominal distension, Injection site pain, Injection site bruising, Injection site swelling, Injection site erythema, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 66 | 26948121 |
US |
67 | 2 |
Tremor, Anxiety, Gastrointestinal disorder, Nervousness, Muscle fatigue, Myalgia, Heart rate increased, |
||||
ABALOPARATIDE, GABAPENTIN, DULOXETINE HYDROCHLORIDE, ROSUVASTATIN, |
||||
| 67 | 26948210 |
US |
2 | |
Gastrointestinal disorder, Drug interaction, Sciatica, Bone pain, Headache, |
||||
ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, TAZAROTENE, |
||||
| 68 | 26948252 |
US |
2 | |
Nervousness, Illness, Reactive gastropathy, Gastrointestinal disorder, Product dose omission issue, Product administration error, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 69 | 26948287 |
53 | ||
Lactose intolerance, Gastrointestinal disorder, Pain, |
||||
PITAVASTATIN CALCIUM, PITAVASTATIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ROSUVASTATIN, |
||||
| 70 | 26951170 |
78 | 1 | |
Gastrointestinal disorder, |
||||
LENALIDOMIDE, BORTEZOMIB, |
||||
| 71 | 26934117 |
CA |
19 | 2 |
Duodenal ulcer perforation, Swollen joint count increased, Fatigue, Musculoskeletal stiffness, Lung disorder, Autoimmune disorder, Wound, Dyspnoea, Pericarditis, Pruritus, Nasopharyngitis, Infusion related reaction, Liver injury, Condition aggravated, Ill-defined disorder, Malaise, Hepatic enzyme increased, Drug intolerance, Lower respiratory tract infection, Arthralgia, Hypersensitivity, Discomfort, Hypertension, Contusion, Sciatica, Anti-cyclic citrullinated peptide antibody positive, Therapy non-responder, Pemphigus, Psoriatic arthropathy, Joint swelling, Osteoarthritis, Sleep disorder due to general medical condition, insomnia type, Lip dry, Pain, Gastrointestinal disorder, Helicobacter infection, Night sweats, Lower limb fracture, Mobility decreased, Alopecia, C-reactive protein, Stomatitis, Folliculitis, Treatment failure, Weight increased, Rheumatoid arthritis, Confusional state, Rash, Rheumatic fever, Deep vein thrombosis postoperative, Infection, Type 2 diabetes mellitus, Pyrexia, Oedema, Blister, Liver disorder, Urticaria, Injury, Systemic lupus erythematosus, |
||||
PREGABALIN, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, APREMILAST, RITUXIMAB, RITUXIMAB, TOFACITINIB, TOFACITINIB, TOFACITINIB, DICLOFENAC, DICLOFENAC SODIUM, TRAMADOL HYDROCHLORIDE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, OXYCODONE, PREDNISONE, PREDNISONE, ALENDRONATE SODIUM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CELECOXIB, ABATACEPT, ABATACEPT, ABATACEPT, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, NEOMYCIN OINTMENT, LEFLUNOMIDE, ETANERCEPT, ETANERCEPT, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, PREDNISONE, GOLIMUMAB, GOLIMUMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, MELOXICAM, QUETIAPINE FUMARATE, QUETIAPINE, ERGOCALCIFEROL, MAGNESIUM HYDROXIDE, SULFASALAZINE, LISINOPRIL, VITAMIN C, ACETAMINOPHEN AND CODEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, PIROXICAM, ERGOCALCIFEROL, CAFFEINE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RAMIPRIL, LANSOPRAZOLE, ERGOCALCIFEROL, RISEDRONATE SODIUM, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 72 | 26934168 |
|||
Gastrointestinal disorder, |
||||
METOPROLOL TARTRATE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 73 | 26934185 |
|||
Gastrointestinal disorder, |
||||
METOPROLOL TARTRATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 74 | 26934711 |
GB |
||
Gastrointestinal disorder, Diarrhoea, Headache, |
||||
VARENICLINE, VARENICLINE TARTRATE, AMOXICILLIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, AMLODIPINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, EZETIMIBE, LANSOPRAZOLE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MOMETASONE FUROATE, MOMETASONE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL, CARBAMAZEPINE, RAMIPRIL, MORPHINE SULFATE, |
||||
| 75 | 26934824 |
CA |
2 | |
Duodenal ulcer perforation, Wound, Stomatitis, Blister, Irritable bowel syndrome, Condition aggravated, Pain, Infection, Ill-defined disorder, Sinusitis, Folliculitis, Injury, Sleep disorder due to general medical condition, insomnia type, Glossodynia, Pyrexia, Swelling, Arthropathy, Synovitis, Muscle injury, Nasopharyngitis, Confusional state, Sleep disorder, Rheumatoid arthritis, Pericarditis, Joint swelling, Infusion related reaction, General physical health deterioration, Systemic lupus erythematosus, Impaired healing, Peripheral swelling, Contusion, Alopecia, Arthralgia, Lower respiratory tract infection, Fatigue, Pemphigus, Gastrointestinal disorder, Anti-cyclic citrullinated peptide antibody positive, Hand deformity, Hepatic enzyme increased, Weight increased, Discomfort, Abdominal discomfort, Helicobacter infection, Rash, Hypersensitivity, Pruritus, Dyspnoea, Insomnia, Contraindicated product administered, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, ALENDRONATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, RITUXIMAB, LEFLUNOMIDE, OXYCODONE, TOFACITINIB CITRATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, APREPITANT, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CHLORHEXIDINE GLUCONATE, CERTOLIZUMAB PEGOL, FOLIC ACID, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, ADALIMUMAB, ADALIMUMAB, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, INFLIXIMAB, ABATACEPT, SULFASALAZINE, LEFLUNOMIDE, DESOGESTREL AND ETHINYL ESTRADIOL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 76 | 26934881 |
EU |
2 | |
Thrombocytopenia, Rectal haemorrhage, Gastrointestinal obstruction, Mitral valve incompetence, Asthenia, Nausea, Constipation, Gastrointestinal disorder, Frequent bowel movements, Infection, Back pain, Haemorrhoids, Urticaria, Dyspnoea exertional, Sacral pain, Diastolic dysfunction, Anorectal discomfort, Anal fissure, Pruritus, |
||||
BEVACIZUMAB, |
||||
| 77 | 26935355 |
US |
79 | 2 |
Gastrointestinal disorder, Nausea, Off label use, Blood bilirubin increased, |
||||
ENASIDENIB MESYLATE, ENASIDENIB MESYLATE, |
||||
| 78 | 26935405 |
US |
2 | |
Gastrointestinal disorder, Gastroenteritis viral, Headache, Nausea, Abdominal pain lower, Constipation, Diarrhoea, Fatigue, |
||||
TIRZEPATIDE, |
||||
| 79 | 26935425 |
EU |
82 | 1 |
Gastrointestinal disorder, |
||||
ORAL SEMAGLUTIDE, |
||||
| 80 | 26935572 |
US |
2 | |
Gastrointestinal disorder, Nausea, |
||||
TIRZEPATIDE, |
||||
| 81 | 26935726 |
EU |
34 | 1 |
Gastrointestinal disorder, Inflammation of wound, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 82 | 26935767 |
CA |
43 | 2 |
C-reactive protein, Lip dry, Therapeutic product effect incomplete, Liver injury, Drug hypersensitivity, Adverse drug reaction, Normal newborn, Joint swelling, Anti-cyclic citrullinated peptide antibody positive, Hand deformity, Hypercholesterolaemia, Exposure during pregnancy, Glossodynia, Duodenal ulcer perforation, Systemic lupus erythematosus, Confusional state, Contraindicated product administered, Oedema, General physical health deterioration, Blister, Musculoskeletal stiffness, Pericarditis, Hip arthroplasty, Anxiety, Deep vein thrombosis postoperative, Joint range of motion decreased, Pregnancy, Malaise, Chest pain, Abdominal discomfort, Hepatic enzyme increased, Decreased appetite, Nausea, Arthralgia, Hypoaesthesia, Fibromyalgia, Sleep disorder due to general medical condition, insomnia type, Red blood cell sedimentation rate increased, Rheumatic fever, Injury, Pain, Pain in extremity, Paraesthesia, Helicobacter infection, Type 2 diabetes mellitus, Visual impairment, Arthropathy, Gastrointestinal disorder, Infusion related reaction, Osteoarthritis, Retinitis, Irritable bowel syndrome, Pemphigus, Insomnia, Knee arthroplasty, Inflammation, Headache, Fatigue, Autoimmune disorder, Maternal exposure during pregnancy, Intentional product misuse, Oedema peripheral, Wound, Asthma, Drug intolerance, Infection, Rheumatoid factor positive, Asthenia, Discomfort, Treatment failure, Grip strength decreased, Intentional product use issue, C-reactive protein increased, Contusion, Diarrhoea, Arthritis, Rheumatoid arthritis, Rash, Hypertension, Blood cholesterol increased, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, TOFACITINIB CITRATE, LEFLUNOMIDE, TOFACITINIB, TOFACITINIB, VITAMIN C, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CALCIUM GLUCONATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, GOLIMUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, APREMILAST, APREMILAST, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, APREMILAST, APREMILAST, APREMILAST, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, ABATACEPT, ABATACEPT, SARILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ERENUMAB-AOOE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, ERGOCALCIFEROL, LISINOPRIL, CAFFEINE CITRATE, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 83 | 26935813 |
BR |
40 | 1 |
Intestinal resection, Adverse reaction, Therapy interrupted, Frequent bowel movements, Diarrhoea, Groin pain, Back pain, Pain in extremity, Acne, Pruritus, Gastrointestinal disorder, |
||||
PANITUMUMAB, |
||||
| 84 | 26935830 |
EU |
80 | 2 |
Gastrointestinal disorder, Acute kidney injury, Lactic acidosis, Bicytopenia, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, DENOSUMAB, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LETROZOLE, LETROZOLE TABLETS, SPIRONOLACTONE, SIMVASTATIN, |
||||
| 85 | 26935951 |
GB |
59 | 2 |
Headache, Gastrointestinal disorder, Psoriasis, |
||||
AMLODIPINE, |
||||
| 86 | 26935996 |
US |
73 | 2 |
Drug hypersensitivity, Gastrointestinal disorder, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 87 | 26936029 |
US |
||
Gastrointestinal disorder, |
||||
| 88 | 26936033 |
|||
Gastrointestinal disorder, Arthropathy, Product use issue, Rebound effect, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, |
||||
| 89 | 26936108 |
EU |
43 | |
Visual impairment, Gastrointestinal disorder, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, OXAZEPAM, PRAMIPEXOLE, |
||||
| 90 | 26936206 |
US |
50 | 2 |
Thrombotic microangiopathy, Cytopenia, Gastrointestinal disorder, Thrombocytopenia, Drug ineffective, Multi-organ disorder, Shock haemorrhagic, |
||||
PEMETREXED, PEMETREXED DISODIUM, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ROMIPLOSTIM, CARBOPLATIN, PEMBROLIZUMAB, |
||||
| 91 | 26936442 |
US |
42 | |
Gastrointestinal disorder, Dehydration, |
||||
TOLVAPTAN, TOLVAPTAN, |
||||
| 92 | 26936519 |
CN |
61 | 2 |
Gastrointestinal disorder, Vomiting, |
||||
EPIRUBICIN HYDROCHLORIDE, |
||||
| 93 | 26936918 |
US |
2 | |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, |
||||
| 94 | 26937259 |
US |
2 | |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, |
||||
| 95 | 26937597 |
US |
1 | |
Body temperature decreased, Gastrointestinal disorder, Muscular weakness, |
||||
ETEPLIRSEN, |
||||
| 96 | 26937726 |
US |
2 | |
Gastrointestinal disorder, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 97 | 26937797 |
CA |
1 | |
Cholangitis sclerosing, Cytokine release syndrome, Gastrointestinal disorder, Hepatic encephalopathy, Immune effector cell-associated neurotoxicity syndrome, Drug ineffective, |
||||
RITUXIMAB, BENDAMUSTINE HYDROCHLORIDE, BREXUCABTAGENE AUTOLEUCEL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, IBRUTINIB, LACTULOSE, URSODIOL, URSOSIOL, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, |
||||
| 98 | 26938060 |
US |
1 | |
Gastrointestinal disorder, Abdominal distension, Diarrhoea, |
||||
TIRZEPATIDE, |
||||
| 99 | 26938125 |
EU |
59 | 2 |
Abdominal distension, Proctalgia, Nausea, Gastritis, Colitis, Gastrointestinal disorder, Bacterial infection, |
||||
UPADACITINIB, |
||||
| 100 | 26938192 |
US |
2 | |
Gastrointestinal disorder, Gastroenteritis viral, |
||||
TIRZEPATIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30